Last $2.99 USD
Change Today +0.12 / 4.18%
Volume 67.6K
VCEL On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Dominick C. Colangelo Esq.

Chief Executive Officer, President, Treasurer and Director, Vericel Corporation
AgeTotal Calculated CompensationThis person is connected to 8 board members in 2 different organizations across 6 different industries.

See Board Relationships
50$1,445,064
As of Fiscal Year 2013

Background*

Mr. Dominick C. Colangelo, also known as Nick, Esq. has been the Chief Executive Officer and President at Aastrom Biosciences, Inc. since March 01, 2013 and as its Chief Administrative Officer and Treasurer since May 7, 2014. Mr. Colangello served as Managing Director of Lilly BioVentures and Lilly Venture Funds. Mr. Colangello was responsible for directing Lilly's venture investing activities. He led investments in Xenoport, NexCura, Zyomyx, and Fast Track Systems. ...

Read Full Background

Corporate Headquarters*

64 Sidney Sreet
Cambridge, Massachusetts 02139

United States

Phone: 617-252-7999
Fax: 617-252-7550

Board Members Memberships*

Former Director
Former Director
Director
Former Director
2009-2012
Former Chief Executive Officer, President and Director
2013-Present
Chief Executive Officer, President, Treasurer and Director

Education*

BSBA
University at Buffalo
JD
Duke University School of Law

Other Affiliations*

Annual Compensation*

Salary$358,333
Total Annual Compensation$358,333

Stock Options*

All Other Compensation$59,264
Unexercisable Options55,001
Total Number of Options55,001

Total Compensation*

Total Annual Cash Compensation$507,180
Total Short Term Compensation$358,333
Other Long Term Compensation$59,264
Total Calculated Compensation$1,445,064
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VCEL:US $2.99 USD +0.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robin C. Stracey Interim Chief Executive Officer, Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Governance & Nominating Committee
Cesca Therapeutics Inc.
--
Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
$406.6K
Martin M. McGlynn Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc
StemCells Inc.
$835.8K
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
$945.0K
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
$467.3K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERICEL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.